Jannik Stemler
Overview
Explore the profile of Jannik Stemler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
602
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bal A, Pana Z, Carlesse F, Marek A, Seidel D, Mehler K, et al.
Mycoses
. 2025 Mar;
68(3):e70041.
PMID: 40071950
Candidaemia in children is associated with high mortality. The epidemiology of Candida bloodstream infection is changing with rising rates of fluconazole resistance worldwide and the emergence of novel multidrug-resistant species...
2.
Kalkan A, Pennig L, Pfister R, Cornely O, Stemler J
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf044.
PMID: 40061103
Background: Midostaurin is a multikinase inhibitor for the treatment of Fms-like tyrosine 3 ()-mutated acute myeloid leukaemia (AML). Cardiac adverse events like QTc-prolongation, pericardial effusion, and congestive heart failure have...
3.
Sandherr M, Stemler J, Schalk E, Hattenhauer T, Hentrich M, Hertenstein B, et al.
Lancet Reg Health Eur
. 2025 Feb;
51:101214.
PMID: 39973942
Febrile Neutropenia is an emergency in the treatment of cancer patients. It requires prompt and evidence-based clinical and antimicrobial management. The implementation of standard operating procedures (SOP) across hospitals and...
4.
Cornely O, Sprute R, Bassetti M, Chen S, Groll A, Kurzai O, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 39956121
Candida species are the predominant cause of fungal infections in patients treated in hospital, contributing substantially to morbidity and mortality. Candidaemia and other forms of invasive candidiasis primarily affect patients...
5.
Richardson T, Schutte D, Kobbe G, Baermann B, Holderried T, Schmitz F, et al.
Blood Adv
. 2025 Jan;
9(6):1370-1375.
PMID: 39746178
No abstract available.
6.
Reinhold I, Cornely O, Stemler J
N Engl J Med
. 2024 Dec;
391(24):2386-2387.
PMID: 39693558
No abstract available.
7.
Herrmann S, Graefe S, Christopeit M, Sonnemann P, Hattenhauer T, Mispelbaum R, et al.
Infection
. 2024 Dec;
PMID: 39688808
Purpose: This study aims to evaluate the burden of respiratory syncytial virus (RSV) infections in patients with haematological diseases. It seeks to analyse the relevance of prevention, diagnosis and treatment...
8.
Stemler J, Gavriilaki E, Hlukhareva O, Khanna N, Neofytos D, Akova M, et al.
Ther Adv Infect Dis
. 2024 Nov;
11:20499361241271863.
PMID: 39493728
Background: Bacterial infections frequently occur in haematological patients, especially during prolonged neutropenia after intensive chemotherapy, often leading to bloodstream infections and pneumonia. Objective: Routine antimicrobial prophylaxis (AMP) for high-risk haematology...
9.
Preyer L, Vettorazzi E, Fiedler W, Rohde H, Stemler J, Gonner S, et al.
Front Oncol
. 2024 Nov;
14:1429221.
PMID: 39484033
Introduction: Our monocentric and retrospective study aimed to investigate the clinical effectivity of HEPA filters in combination with the antifungal drug prophylaxis in patients with AML undergoing intensive chemotherapy and...
10.
Hurrass J, Heinzow B, Walser-Reichenbach S, Aurbach U, Becker S, Bellmann R, et al.
Pneumologie
. 2024 Oct;
78(10):693-784.
PMID: 39424320
This article is an abridged version of the updated AWMF mould guideline "Medical clinical diagnostics in case of indoor mould exposure - Update 2023", presented in July 2023 by the...